Clinical Trial

A Multicentre Observational Cross-Sectional Study of The Gastric Precancerous Epithelial Pathway Using High-Definition Endoscopy And Histopathology In India

Study acronym: IND-PREP
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
To estimate the prevalence of histologically confirmed early gastric cancer (EGC) in an Indian multicentre cohort undergoing standardised high-quality upper gastrointestinal endoscopy. EGC is defined as gastric adenocarcinoma confined to the mucosa or submucosa (T1), irrespective of lymph node status, based on histopathology.
Protocol Amendment History 1 change
minor Completion pushed: 2028-04-01 -> 2028-07-01 2026-06-03
Trial Details
NCT Number NCT07486518
Lead Sponsor Asian Institute of Gastroenterology, India
Conditions Gastric Adenocarcinoma, Early Gastric Cancer
Enrollment 4,000 participants
Start Date 2026-07-01
Primary Completion 2028-04-01 (estimated)
Study Completion 2028-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-04